Skip to main content

Table 4 Costs related to advanced NSCLC stratified by patients and caregivers

From: Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage

Mean annual costs per patient/caregiver

Patients

(N = 1030)

Caregivers

(N = 427)

Wage losses

n = 1000

€2077

n = 360

€436

Direct out-of-pocket expenses (unadjusted)

n = 544

€3774

n = 213

€1756

Direct out-of-pocket expenses (adjusteda)

n = 539

€823

n = 203

€1019

Productivity losses

n = 966

€1484

n = 387

€2839

Total direct and indirect out-of-pocket costs (unadjusted)

n = 522

€5691

n = 204

€4125

Financial support received from government

n = 989

€2110

n = 386

€721

Total direct and indirect out-of-pocket costs (adjusteda)

n = 518

€2644

n = 194

€3477

  1. NSCLC non-small cell lung cancer
  2. aAdjusted for financial support provided by the respective governments